Lawrence Samuel Friedman, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastroenterology | 12 | 2024 | 577 | 2.190 |
Why?
|
| Liver Diseases | 19 | 2024 | 1297 | 2.060 |
Why?
|
| Gastrointestinal Hemorrhage | 10 | 2008 | 1116 | 0.880 |
Why?
|
| Psychoanalytic Therapy | 2 | 2013 | 228 | 0.740 |
Why?
|
| Liver | 12 | 2017 | 7528 | 0.640 |
Why?
|
| Blood Coagulation Disorders | 1 | 2021 | 350 | 0.600 |
Why?
|
| Hares | 1 | 2016 | 4 | 0.560 |
Why?
|
| Turtles | 1 | 2016 | 40 | 0.560 |
Why?
|
| Liver Failure, Acute | 2 | 2016 | 181 | 0.560 |
Why?
|
| Hepatitis C | 11 | 2015 | 1584 | 0.530 |
Why?
|
| Hepatitis, Viral, Human | 6 | 2010 | 141 | 0.520 |
Why?
|
| Hepatitis A | 4 | 2010 | 128 | 0.510 |
Why?
|
| Hepatitis E | 1 | 2016 | 76 | 0.510 |
Why?
|
| Gift Giving | 1 | 2015 | 76 | 0.500 |
Why?
|
| Liver Cirrhosis | 9 | 2021 | 1935 | 0.500 |
Why?
|
| Hepatitis B virus | 7 | 2004 | 528 | 0.460 |
Why?
|
| Education, Medical | 4 | 2015 | 1725 | 0.460 |
Why?
|
| Health Care Sector | 1 | 2015 | 195 | 0.450 |
Why?
|
| Endoscopy, Gastrointestinal | 7 | 2009 | 874 | 0.440 |
Why?
|
| Thrombocytopenia | 1 | 2021 | 1182 | 0.440 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2010 | 572 | 0.430 |
Why?
|
| Simethicone | 1 | 2012 | 15 | 0.430 |
Why?
|
| Bisacodyl | 1 | 2012 | 12 | 0.420 |
Why?
|
| Psychoanalytic Theory | 1 | 2013 | 138 | 0.420 |
Why?
|
| Liver Transplantation | 11 | 2019 | 2330 | 0.420 |
Why?
|
| Citric Acid | 1 | 2012 | 123 | 0.410 |
Why?
|
| Clinical Medicine | 1 | 2014 | 145 | 0.410 |
Why?
|
| Editorial Policies | 1 | 2017 | 458 | 0.390 |
Why?
|
| Hepatolenticular Degeneration | 4 | 2010 | 72 | 0.390 |
Why?
|
| Cathartics | 1 | 2012 | 127 | 0.390 |
Why?
|
| Lead Poisoning | 1 | 2014 | 322 | 0.380 |
Why?
|
| Guidelines as Topic | 3 | 2009 | 1386 | 0.380 |
Why?
|
| Colonic Diseases, Functional | 3 | 1996 | 39 | 0.370 |
Why?
|
| Cholestasis | 2 | 2013 | 378 | 0.370 |
Why?
|
| Colonoscopy | 4 | 2012 | 1394 | 0.360 |
Why?
|
| Conflict of Interest | 1 | 2015 | 554 | 0.360 |
Why?
|
| Hepatitis B | 7 | 1994 | 705 | 0.360 |
Why?
|
| Abdominal Pain | 2 | 2014 | 1071 | 0.350 |
Why?
|
| Universities | 2 | 2015 | 993 | 0.350 |
Why?
|
| Inflammatory Bowel Diseases | 4 | 2018 | 2422 | 0.340 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2018 | 1881 | 0.310 |
Why?
|
| Viral Hepatitis Vaccines | 4 | 1993 | 72 | 0.310 |
Why?
|
| Advisory Committees | 2 | 2009 | 787 | 0.310 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2010 | 172 | 0.310 |
Why?
|
| Lead | 1 | 2014 | 879 | 0.300 |
Why?
|
| Liver Circulation | 3 | 2010 | 159 | 0.300 |
Why?
|
| Aminosalicylic Acids | 4 | 1989 | 37 | 0.300 |
Why?
|
| Ethics, Medical | 1 | 2013 | 783 | 0.300 |
Why?
|
| Polyethylene Glycols | 2 | 2015 | 1189 | 0.300 |
Why?
|
| Dyspepsia | 2 | 1999 | 116 | 0.290 |
Why?
|
| Sarcoidosis | 1 | 2013 | 521 | 0.280 |
Why?
|
| Enema | 4 | 1989 | 141 | 0.280 |
Why?
|
| Practice Guidelines as Topic | 6 | 2017 | 7391 | 0.280 |
Why?
|
| Societies, Medical | 5 | 2024 | 3905 | 0.260 |
Why?
|
| Teaching | 1 | 2014 | 1170 | 0.260 |
Why?
|
| Certification | 1 | 2009 | 418 | 0.260 |
Why?
|
| Amyloidosis | 1 | 2013 | 817 | 0.260 |
Why?
|
| Anti-Ulcer Agents | 2 | 1998 | 112 | 0.260 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2007 | 189 | 0.260 |
Why?
|
| Liver Function Tests | 4 | 2016 | 523 | 0.260 |
Why?
|
| Myxoma | 1 | 2006 | 114 | 0.250 |
Why?
|
| Periodicals as Topic | 1 | 2017 | 1463 | 0.250 |
Why?
|
| Helicobacter pylori | 2 | 1999 | 377 | 0.250 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2011 | 617 | 0.250 |
Why?
|
| Helicobacter Infections | 2 | 1999 | 388 | 0.250 |
Why?
|
| Muscle Neoplasms | 1 | 2006 | 130 | 0.250 |
Why?
|
| Ambulatory Care | 2 | 2015 | 2775 | 0.240 |
Why?
|
| Awards and Prizes | 1 | 2009 | 360 | 0.240 |
Why?
|
| End Stage Liver Disease | 2 | 2019 | 352 | 0.240 |
Why?
|
| Travel | 1 | 2010 | 796 | 0.240 |
Why?
|
| Physician-Patient Relations | 2 | 2019 | 3251 | 0.230 |
Why?
|
| Humans | 120 | 2024 | 761596 | 0.230 |
Why?
|
| Anemia, Sickle Cell | 3 | 2013 | 1063 | 0.230 |
Why?
|
| Antidiarrheals | 1 | 2004 | 46 | 0.230 |
Why?
|
| Motivation | 1 | 2013 | 2006 | 0.220 |
Why?
|
| Diarrhea | 3 | 2004 | 1318 | 0.210 |
Why?
|
| Hepatitis | 3 | 2013 | 228 | 0.210 |
Why?
|
| Hepatitis, Alcoholic | 2 | 2017 | 109 | 0.200 |
Why?
|
| Peptic Ulcer | 3 | 1994 | 217 | 0.190 |
Why?
|
| Venous Thrombosis | 1 | 2011 | 1303 | 0.190 |
Why?
|
| Colitis, Ulcerative | 7 | 1999 | 1922 | 0.190 |
Why?
|
| Preoperative Care | 3 | 2009 | 2242 | 0.180 |
Why?
|
| Postoperative Complications | 5 | 2018 | 15633 | 0.170 |
Why?
|
| Colitis | 4 | 1992 | 1233 | 0.170 |
Why?
|
| Hepatitis B, Chronic | 1 | 2004 | 410 | 0.170 |
Why?
|
| Blood Donors | 3 | 1992 | 345 | 0.170 |
Why?
|
| History, 20th Century | 4 | 2015 | 2767 | 0.160 |
Why?
|
| Hemostasis | 1 | 2021 | 467 | 0.160 |
Why?
|
| Sepsis | 1 | 2013 | 2585 | 0.160 |
Why?
|
| Biopsy, Needle | 1 | 2004 | 1626 | 0.160 |
Why?
|
| Acute Disease | 6 | 2014 | 7237 | 0.150 |
Why?
|
| Gastrointestinal Tract | 1 | 2004 | 833 | 0.150 |
Why?
|
| Omeprazole | 1 | 1998 | 105 | 0.150 |
Why?
|
| Antifungal Agents | 1 | 2003 | 753 | 0.150 |
Why?
|
| Hepatovirus | 3 | 1993 | 45 | 0.150 |
Why?
|
| Diagnosis, Differential | 6 | 2016 | 12973 | 0.150 |
Why?
|
| Anti-Bacterial Agents | 3 | 2003 | 7406 | 0.150 |
Why?
|
| Disease Management | 2 | 2018 | 2508 | 0.140 |
Why?
|
| Alanine Transaminase | 4 | 2005 | 603 | 0.140 |
Why?
|
| Autoimmune Diseases | 3 | 2013 | 2244 | 0.140 |
Why?
|
| Orthopedic Procedures | 1 | 2007 | 1265 | 0.140 |
Why?
|
| Biopsy | 3 | 2005 | 6766 | 0.140 |
Why?
|
| Esophagogastric Junction | 1 | 1999 | 347 | 0.130 |
Why?
|
| Hepatitis B Surface Antigens | 5 | 2004 | 294 | 0.130 |
Why?
|
| Gastrointestinal Diseases | 1 | 2024 | 1200 | 0.130 |
Why?
|
| Ceruloplasmin | 2 | 1992 | 56 | 0.130 |
Why?
|
| Ultrasonography | 4 | 2016 | 5971 | 0.130 |
Why?
|
| Crohn Disease | 4 | 2018 | 2279 | 0.130 |
Why?
|
| Infertility, Male | 2 | 1989 | 395 | 0.120 |
Why?
|
| Aspartate Aminotransferases | 2 | 2007 | 416 | 0.120 |
Why?
|
| Interinstitutional Relations | 1 | 2015 | 236 | 0.120 |
Why?
|
| Acquired Immunodeficiency Syndrome | 3 | 1992 | 2199 | 0.120 |
Why?
|
| Peritonitis | 2 | 1996 | 368 | 0.120 |
Why?
|
| Porphyrias | 1 | 2014 | 57 | 0.120 |
Why?
|
| Hypertension, Portal | 1 | 1996 | 226 | 0.110 |
Why?
|
| Attitude | 1 | 2019 | 775 | 0.110 |
Why?
|
| Hepatitis B Antibodies | 4 | 2004 | 155 | 0.110 |
Why?
|
| Palliative Care | 2 | 2019 | 3598 | 0.110 |
Why?
|
| Cholecystitis | 1 | 1994 | 180 | 0.110 |
Why?
|
| Transaminases | 1 | 2014 | 199 | 0.110 |
Why?
|
| Diverticulum, Colon | 1 | 1992 | 32 | 0.110 |
Why?
|
| Vaccines, Inactivated | 1 | 1993 | 179 | 0.110 |
Why?
|
| Surgical Procedures, Operative | 2 | 1999 | 1924 | 0.100 |
Why?
|
| Kidney Failure, Chronic | 2 | 2015 | 2472 | 0.100 |
Why?
|
| Jaundice | 2 | 2010 | 94 | 0.100 |
Why?
|
| United States | 13 | 2019 | 72340 | 0.100 |
Why?
|
| Hepatitis, Chronic | 1 | 1992 | 52 | 0.100 |
Why?
|
| Cryoglobulinemia | 1 | 1992 | 84 | 0.100 |
Why?
|
| Zinc | 2 | 1993 | 690 | 0.100 |
Why?
|
| Morbidity | 3 | 2008 | 1752 | 0.100 |
Why?
|
| Listeriosis | 1 | 1992 | 149 | 0.100 |
Why?
|
| Anemia, Pernicious | 1 | 1991 | 15 | 0.100 |
Why?
|
| Advance Care Planning | 1 | 2019 | 699 | 0.100 |
Why?
|
| Interferon-alpha | 2 | 2015 | 921 | 0.100 |
Why?
|
| Peptic Ulcer Hemorrhage | 1 | 1991 | 47 | 0.090 |
Why?
|
| Pyloric Antrum | 1 | 1991 | 66 | 0.090 |
Why?
|
| Sulfasalazine | 2 | 1989 | 84 | 0.090 |
Why?
|
| Food Microbiology | 1 | 1991 | 74 | 0.090 |
Why?
|
| Prognosis | 8 | 2014 | 29629 | 0.090 |
Why?
|
| Hepatitis D | 2 | 1987 | 23 | 0.090 |
Why?
|
| Spouse Abuse | 1 | 1992 | 182 | 0.090 |
Why?
|
| Perioperative Care | 1 | 2018 | 1036 | 0.090 |
Why?
|
| Dyslipidemias | 1 | 2018 | 868 | 0.090 |
Why?
|
| Endocrine System Diseases | 1 | 2013 | 249 | 0.090 |
Why?
|
| Pregnancy Complications | 1 | 2024 | 2947 | 0.090 |
Why?
|
| Clinical Enzyme Tests | 2 | 1987 | 113 | 0.090 |
Why?
|
| Education, Medical, Graduate | 2 | 2000 | 2373 | 0.090 |
Why?
|
| Male | 32 | 2019 | 360846 | 0.090 |
Why?
|
| Isoantibodies | 1 | 2014 | 674 | 0.090 |
Why?
|
| Immunocompromised Host | 1 | 1995 | 858 | 0.080 |
Why?
|
| Somatostatin | 1 | 1991 | 447 | 0.080 |
Why?
|
| Mycoses | 1 | 2013 | 386 | 0.080 |
Why?
|
| Microwaves | 1 | 1991 | 185 | 0.080 |
Why?
|
| Colonic Neoplasms | 2 | 1999 | 2539 | 0.080 |
Why?
|
| Cyclosporins | 2 | 1989 | 216 | 0.080 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2013 | 269 | 0.080 |
Why?
|
| Stress, Psychological | 1 | 2004 | 4481 | 0.080 |
Why?
|
| Disease Outbreaks | 2 | 1991 | 1749 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2015 | 1567 | 0.080 |
Why?
|
| Intraoperative Period | 1 | 2010 | 510 | 0.080 |
Why?
|
| Colorectal Neoplasms | 3 | 2010 | 6938 | 0.080 |
Why?
|
| Risk Factors | 11 | 2010 | 74213 | 0.080 |
Why?
|
| Diverticulum | 2 | 1994 | 137 | 0.080 |
Why?
|
| Esophageal Neoplasms | 1 | 1999 | 1654 | 0.080 |
Why?
|
| HLA Antigens | 1 | 2014 | 1328 | 0.080 |
Why?
|
| Autoimmunity | 1 | 1996 | 1356 | 0.080 |
Why?
|
| Sperm-Ovum Interactions | 1 | 1988 | 23 | 0.080 |
Why?
|
| Curriculum | 2 | 2009 | 3743 | 0.080 |
Why?
|
| Gallstones | 1 | 2010 | 284 | 0.080 |
Why?
|
| Immunity | 1 | 1994 | 996 | 0.080 |
Why?
|
| Competency-Based Education | 1 | 2009 | 222 | 0.070 |
Why?
|
| Middle Aged | 22 | 2016 | 220921 | 0.070 |
Why?
|
| Adenocarcinoma | 2 | 1999 | 6345 | 0.070 |
Why?
|
| Pancreatitis | 2 | 1993 | 1096 | 0.070 |
Why?
|
| Bilirubin | 3 | 2007 | 436 | 0.070 |
Why?
|
| Female | 33 | 2024 | 392705 | 0.070 |
Why?
|
| Nausea | 1 | 2010 | 679 | 0.070 |
Why?
|
| Pruritus | 1 | 2010 | 380 | 0.070 |
Why?
|
| Hepatitis C, Chronic | 1 | 2015 | 1032 | 0.070 |
Why?
|
| Mesalamine | 4 | 1989 | 135 | 0.070 |
Why?
|
| Hemostatic Techniques | 1 | 2008 | 112 | 0.070 |
Why?
|
| Colon | 2 | 1994 | 1792 | 0.070 |
Why?
|
| Hepatitis B Vaccines | 3 | 1993 | 178 | 0.070 |
Why?
|
| Fatigue | 1 | 2014 | 1552 | 0.070 |
Why?
|
| Survival Rate | 3 | 2008 | 12723 | 0.070 |
Why?
|
| Minnesota | 1 | 2007 | 338 | 0.070 |
Why?
|
| Antiviral Agents | 2 | 2015 | 3060 | 0.070 |
Why?
|
| Pancreas | 1 | 1993 | 1691 | 0.070 |
Why?
|
| Pharmaceutical Preparations | 2 | 2010 | 1089 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 3 | 2004 | 6075 | 0.060 |
Why?
|
| Hepacivirus | 4 | 2015 | 1336 | 0.060 |
Why?
|
| Carcinoma in Situ | 1 | 1991 | 791 | 0.060 |
Why?
|
| Mesencephalon | 1 | 1987 | 332 | 0.060 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 2759 | 0.060 |
Why?
|
| Alkaline Phosphatase | 3 | 2005 | 864 | 0.060 |
Why?
|
| Recurrence | 5 | 2005 | 8466 | 0.060 |
Why?
|
| Erythrocytes | 1 | 2014 | 2413 | 0.060 |
Why?
|
| Abdomen | 1 | 2010 | 1128 | 0.060 |
Why?
|
| Hepatic Encephalopathy | 2 | 1996 | 144 | 0.060 |
Why?
|
| Anemia | 1 | 2014 | 1509 | 0.060 |
Why?
|
| Acute Kidney Injury | 1 | 2016 | 1924 | 0.060 |
Why?
|
| Learning | 1 | 2014 | 1740 | 0.060 |
Why?
|
| Education, Medical, Continuing | 1 | 2009 | 823 | 0.060 |
Why?
|
| Tissue Donors | 1 | 2014 | 2332 | 0.060 |
Why?
|
| Heart Failure | 2 | 2013 | 11671 | 0.060 |
Why?
|
| Lactose Intolerance | 1 | 2004 | 28 | 0.060 |
Why?
|
| Hepatitis B e Antigens | 1 | 2004 | 133 | 0.060 |
Why?
|
| Jejunal Diseases | 1 | 1984 | 46 | 0.060 |
Why?
|
| Ascites | 2 | 1996 | 338 | 0.060 |
Why?
|
| Sex Distribution | 2 | 1999 | 2280 | 0.060 |
Why?
|
| 4-Quinolones | 1 | 2003 | 25 | 0.060 |
Why?
|
| Lymphoma | 1 | 2013 | 1901 | 0.060 |
Why?
|
| Nitrofurantoin | 1 | 2003 | 18 | 0.050 |
Why?
|
| Hepatitis Antibodies | 4 | 1994 | 67 | 0.050 |
Why?
|
| Fabry Disease | 1 | 1984 | 87 | 0.050 |
Why?
|
| RNA, Viral | 3 | 2015 | 2846 | 0.050 |
Why?
|
| Attitude to Health | 1 | 1992 | 2025 | 0.050 |
Why?
|
| Postoperative Care | 1 | 2010 | 1468 | 0.050 |
Why?
|
| Preconception Care | 1 | 2024 | 141 | 0.050 |
Why?
|
| Age Distribution | 2 | 1999 | 2879 | 0.050 |
Why?
|
| Graft Rejection | 2 | 2014 | 4446 | 0.050 |
Why?
|
| Collagen | 1 | 1991 | 2638 | 0.050 |
Why?
|
| Physical Examination | 2 | 2005 | 1255 | 0.050 |
Why?
|
| Tetracycline | 1 | 2003 | 216 | 0.050 |
Why?
|
| Age Factors | 4 | 2008 | 18399 | 0.050 |
Why?
|
| Health Services Research | 1 | 2010 | 1812 | 0.050 |
Why?
|
| Vaccination | 2 | 1991 | 3384 | 0.050 |
Why?
|
| Chronic Disease | 5 | 1996 | 9319 | 0.050 |
Why?
|
| Cephalosporins | 1 | 2003 | 198 | 0.050 |
Why?
|
| Monitoring, Physiologic | 1 | 2010 | 1779 | 0.050 |
Why?
|
| Intestinal Perforation | 1 | 1984 | 249 | 0.050 |
Why?
|
| Macrolides | 1 | 2003 | 205 | 0.050 |
Why?
|
| Problem-Based Learning | 1 | 2005 | 356 | 0.050 |
Why?
|
| Virus Replication | 2 | 2004 | 2435 | 0.050 |
Why?
|
| Radionuclide Imaging | 1 | 2005 | 1972 | 0.050 |
Why?
|
| Stents | 1 | 1993 | 3179 | 0.050 |
Why?
|
| Treatment Outcome | 6 | 2015 | 64685 | 0.050 |
Why?
|
| Aged | 15 | 2015 | 169310 | 0.050 |
Why?
|
| Stomach Neoplasms | 1 | 1991 | 1459 | 0.050 |
Why?
|
| Quality of Health Care | 1 | 2015 | 4331 | 0.040 |
Why?
|
| Risk Assessment | 4 | 2018 | 23996 | 0.040 |
Why?
|
| Adult | 21 | 2015 | 221210 | 0.040 |
Why?
|
| Dopamine | 1 | 1987 | 1607 | 0.040 |
Why?
|
| Quality Indicators, Health Care | 1 | 2010 | 1792 | 0.040 |
Why?
|
| Vaccines, Synthetic | 2 | 1993 | 616 | 0.040 |
Why?
|
| Penicillins | 1 | 2003 | 402 | 0.040 |
Why?
|
| Internship and Residency | 1 | 2000 | 5882 | 0.040 |
Why?
|
| Clinical Competence | 1 | 1995 | 4793 | 0.040 |
Why?
|
| Quality Assurance, Health Care | 1 | 2010 | 2169 | 0.040 |
Why?
|
| Gastrointestinal Agents | 1 | 2004 | 510 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2006 | 36426 | 0.040 |
Why?
|
| Hydrocortisone | 1 | 1986 | 1819 | 0.040 |
Why?
|
| Incidence | 2 | 2010 | 21355 | 0.040 |
Why?
|
| Rural Health | 1 | 1999 | 296 | 0.040 |
Why?
|
| Anaphylaxis | 1 | 1985 | 757 | 0.040 |
Why?
|
| Hepatitis Delta Virus | 2 | 1987 | 24 | 0.040 |
Why?
|
| DNA, Viral | 1 | 2004 | 2202 | 0.040 |
Why?
|
| Endoscopes | 1 | 1998 | 168 | 0.030 |
Why?
|
| Drug Therapy, Combination | 2 | 2015 | 6312 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2009 | 15843 | 0.030 |
Why?
|
| Patient Selection | 1 | 2009 | 4244 | 0.030 |
Why?
|
| Aged, 80 and over | 5 | 2008 | 58984 | 0.030 |
Why?
|
| Urban Health | 1 | 1999 | 532 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2009 | 10090 | 0.030 |
Why?
|
| North America | 1 | 2000 | 1276 | 0.030 |
Why?
|
| Multiple Sclerosis | 1 | 1991 | 3222 | 0.030 |
Why?
|
| Liver Neoplasms | 2 | 1999 | 4317 | 0.030 |
Why?
|
| Bile Ducts | 2 | 1994 | 282 | 0.030 |
Why?
|
| Reperfusion Injury | 1 | 2002 | 1023 | 0.030 |
Why?
|
| Cultural Competency | 1 | 2019 | 301 | 0.030 |
Why?
|
| Hepatorenal Syndrome | 1 | 1996 | 76 | 0.030 |
Why?
|
| Physicians | 1 | 2014 | 4591 | 0.030 |
Why?
|
| Anti-Infective Agents | 1 | 2003 | 983 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1991 | 4024 | 0.030 |
Why?
|
| Pyridines | 1 | 1987 | 2875 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2010 | 3201 | 0.030 |
Why?
|
| Time Factors | 4 | 2019 | 39969 | 0.030 |
Why?
|
| Barrett Esophagus | 1 | 1999 | 492 | 0.030 |
Why?
|
| Heart Arrest | 1 | 1985 | 1514 | 0.030 |
Why?
|
| Antitubercular Agents | 1 | 2003 | 1375 | 0.030 |
Why?
|
| Prostaglandins, Synthetic | 1 | 1994 | 24 | 0.030 |
Why?
|
| Cholecystostomy | 1 | 1994 | 48 | 0.030 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2010 | 3627 | 0.030 |
Why?
|
| Terpenes | 1 | 1994 | 96 | 0.030 |
Why?
|
| Waiting Lists | 1 | 2019 | 765 | 0.030 |
Why?
|
| Meckel Diverticulum | 1 | 1994 | 32 | 0.030 |
Why?
|
| Bismuth | 1 | 1994 | 29 | 0.030 |
Why?
|
| Mass Screening | 1 | 2010 | 5429 | 0.030 |
Why?
|
| Radiography | 1 | 2005 | 6965 | 0.030 |
Why?
|
| Parasympatholytics | 1 | 1994 | 89 | 0.030 |
Why?
|
| HIV-1 | 1 | 1991 | 6863 | 0.030 |
Why?
|
| Air | 1 | 1994 | 187 | 0.030 |
Why?
|
| Ischemia | 1 | 2002 | 1884 | 0.030 |
Why?
|
| Hepatitis A Vaccines | 1 | 1993 | 26 | 0.030 |
Why?
|
| Duodenal Ulcer | 1 | 1993 | 121 | 0.030 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 1993 | 52 | 0.030 |
Why?
|
| Stomach Ulcer | 1 | 1993 | 122 | 0.030 |
Why?
|
| Mesenteric Arteries | 1 | 1994 | 178 | 0.030 |
Why?
|
| Ribavirin | 1 | 2015 | 395 | 0.030 |
Why?
|
| Adenoma | 1 | 1984 | 2163 | 0.030 |
Why?
|
| Metallothionein | 1 | 1993 | 61 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2003 | 1979 | 0.030 |
Why?
|
| Chemoreceptor Cells | 1 | 1993 | 89 | 0.030 |
Why?
|
| Intussusception | 1 | 1994 | 115 | 0.030 |
Why?
|
| Trientine | 1 | 1992 | 12 | 0.030 |
Why?
|
| Ampicillin | 1 | 1992 | 136 | 0.030 |
Why?
|
| Colectomy | 1 | 1998 | 688 | 0.030 |
Why?
|
| Zinc Sulfate | 1 | 1992 | 18 | 0.030 |
Why?
|
| Rectal Diseases | 1 | 1994 | 143 | 0.030 |
Why?
|
| Ulcer | 1 | 1994 | 204 | 0.030 |
Why?
|
| Penicillamine | 1 | 1992 | 60 | 0.030 |
Why?
|
| Hepatitis B Core Antigens | 1 | 1992 | 90 | 0.030 |
Why?
|
| Animals | 5 | 2016 | 168475 | 0.030 |
Why?
|
| Varicose Veins | 1 | 1994 | 155 | 0.030 |
Why?
|
| Colonic Diseases | 1 | 1994 | 201 | 0.030 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 2 | 1993 | 506 | 0.020 |
Why?
|
| HIV Seroprevalence | 1 | 1992 | 89 | 0.020 |
Why?
|
| Immunoblotting | 2 | 1992 | 1646 | 0.020 |
Why?
|
| Copper Radioisotopes | 1 | 1992 | 91 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2010 | 39106 | 0.020 |
Why?
|
| Ophthalmoscopy | 1 | 1992 | 171 | 0.020 |
Why?
|
| Cryptosporidiosis | 1 | 1991 | 52 | 0.020 |
Why?
|
| Anemia, Hypochromic | 1 | 1991 | 63 | 0.020 |
Why?
|
| Appetite | 1 | 1993 | 247 | 0.020 |
Why?
|
| Sulfates | 1 | 1992 | 380 | 0.020 |
Why?
|
| Tennessee | 1 | 1991 | 120 | 0.020 |
Why?
|
| Intestinal Mucosa | 2 | 1993 | 3032 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2015 | 80647 | 0.020 |
Why?
|
| Research Report | 1 | 2014 | 367 | 0.020 |
Why?
|
| Immunosuppressive Agents | 2 | 1996 | 4176 | 0.020 |
Why?
|
| Vasculitis | 1 | 1994 | 521 | 0.020 |
Why?
|
| Food Preferences | 1 | 1993 | 398 | 0.020 |
Why?
|
| Dilatation, Pathologic | 1 | 1991 | 527 | 0.020 |
Why?
|
| Copper | 1 | 1992 | 369 | 0.020 |
Why?
|
| Radioimmunoassay | 2 | 1991 | 861 | 0.020 |
Why?
|
| Intestinal Diseases | 1 | 1994 | 504 | 0.020 |
Why?
|
| Endoscopy, Digestive System | 1 | 1992 | 351 | 0.020 |
Why?
|
| Running | 1 | 1994 | 488 | 0.020 |
Why?
|
| Child | 5 | 2007 | 80158 | 0.020 |
Why?
|
| Catheterization | 1 | 1994 | 1428 | 0.020 |
Why?
|
| Diverticulitis, Colonic | 1 | 1990 | 138 | 0.020 |
Why?
|
| Plasmapheresis | 1 | 1989 | 206 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 14665 | 0.020 |
Why?
|
| Drainage | 1 | 1994 | 1157 | 0.020 |
Why?
|
| Restaurants | 1 | 1991 | 231 | 0.020 |
Why?
|
| Neurons | 1 | 1987 | 9463 | 0.020 |
Why?
|
| Anesthesia | 1 | 1999 | 1595 | 0.020 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 1 | 1987 | 34 | 0.020 |
Why?
|
| Israel | 1 | 1990 | 726 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 26129 | 0.020 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 1987 | 89 | 0.020 |
Why?
|
| Pyridinium Compounds | 1 | 1987 | 81 | 0.020 |
Why?
|
| Immunologic Techniques | 1 | 1987 | 212 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2005 | 20100 | 0.020 |
Why?
|
| Autoantibodies | 1 | 1996 | 2118 | 0.020 |
Why?
|
| Random Allocation | 2 | 1993 | 2395 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1999 | 2297 | 0.020 |
Why?
|
| Radiation Injuries | 1 | 1994 | 1189 | 0.020 |
Why?
|
| Pregnancy | 2 | 2024 | 29890 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2010 | 793 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 1987 | 698 | 0.020 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 1987 | 370 | 0.020 |
Why?
|
| Viral Load | 1 | 2015 | 3332 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2019 | 3600 | 0.020 |
Why?
|
| Drug Monitoring | 1 | 1992 | 962 | 0.020 |
Why?
|
| Gardner Syndrome | 1 | 1985 | 3 | 0.020 |
Why?
|
| Hepatitis A Antibodies | 1 | 1985 | 19 | 0.020 |
Why?
|
| Sigmoidoscopy | 1 | 1986 | 151 | 0.020 |
Why?
|
| Endometriosis | 1 | 1994 | 870 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 1995 | 1796 | 0.020 |
Why?
|
| Dietary Fats | 1 | 1993 | 1995 | 0.020 |
Why?
|
| Blood Vessels | 1 | 1991 | 1113 | 0.020 |
Why?
|
| HIV Infections | 1 | 1992 | 17354 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 1999 | 7828 | 0.020 |
Why?
|
| Occult Blood | 1 | 1986 | 198 | 0.020 |
Why?
|
| Deglutition Disorders | 1 | 1991 | 625 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 1996 | 3156 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 3889 | 0.020 |
Why?
|
| Common Bile Duct Neoplasms | 1 | 1985 | 120 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1992 | 3810 | 0.020 |
Why?
|
| Drug Evaluation | 1 | 1986 | 641 | 0.020 |
Why?
|
| Infusions, Parenteral | 1 | 1985 | 397 | 0.010 |
Why?
|
| Ampulla of Vater | 1 | 1985 | 149 | 0.010 |
Why?
|
| Communication | 1 | 2019 | 3875 | 0.010 |
Why?
|
| South Africa | 1 | 1990 | 1843 | 0.010 |
Why?
|
| Educational Status | 1 | 1992 | 2522 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1996 | 8527 | 0.010 |
Why?
|
| Epitopes | 1 | 1991 | 2503 | 0.010 |
Why?
|
| Forecasting | 1 | 1993 | 2928 | 0.010 |
Why?
|
| Ranitidine | 1 | 1983 | 34 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1992 | 4021 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 59260 | 0.010 |
Why?
|
| Intestines | 1 | 1993 | 1910 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 1999 | 11120 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1993 | 2273 | 0.010 |
Why?
|
| Serologic Tests | 1 | 1985 | 381 | 0.010 |
Why?
|
| Europe | 1 | 1990 | 3420 | 0.010 |
Why?
|
| Algorithms | 1 | 2003 | 14033 | 0.010 |
Why?
|
| Endoscopy | 1 | 1993 | 1851 | 0.010 |
Why?
|
| Liver Cirrhosis, Biliary | 2 | 1994 | 108 | 0.010 |
Why?
|
| Patient Participation | 1 | 1992 | 1445 | 0.010 |
Why?
|
| Data Collection | 1 | 1992 | 3322 | 0.010 |
Why?
|
| Prevalence | 2 | 2010 | 15733 | 0.010 |
Why?
|
| Rectum | 1 | 1987 | 892 | 0.010 |
Why?
|
| Sexual Behavior | 1 | 1992 | 2180 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 1990 | 1391 | 0.010 |
Why?
|
| Contraceptives, Oral | 1 | 1984 | 554 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1987 | 2231 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 1989 | 2386 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 1994 | 5493 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1984 | 1152 | 0.010 |
Why?
|
| Genotype | 1 | 2015 | 12990 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 1985 | 1526 | 0.010 |
Why?
|
| Colonic Polyps | 1 | 1985 | 554 | 0.010 |
Why?
|
| Abscess | 1 | 1984 | 606 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 1995 | 4235 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2010 | 2598 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1987 | 4853 | 0.010 |
Why?
|
| Boston | 1 | 1992 | 9327 | 0.010 |
Why?
|
| Adolescent | 4 | 1994 | 88326 | 0.010 |
Why?
|
| Genetic Testing | 1 | 1992 | 3537 | 0.010 |
Why?
|
| Angiography | 1 | 1984 | 1595 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 3688 | 0.010 |
Why?
|
| Medical Oncology | 1 | 2009 | 2321 | 0.010 |
Why?
|
| Quality of Life | 1 | 1999 | 13367 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 1993 | 12341 | 0.010 |
Why?
|
| Diet | 1 | 1994 | 8075 | 0.010 |
Why?
|
| Prospective Studies | 2 | 1993 | 54423 | 0.010 |
Why?
|
| Rats | 2 | 1993 | 23741 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 1992 | 15266 | 0.010 |
Why?
|
| Risk | 1 | 1987 | 9610 | 0.010 |
Why?
|
| Cyclohexenes | 1 | 1994 | 15 | 0.010 |
Why?
|
| Citrus | 1 | 1994 | 49 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 1987 | 4028 | 0.010 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 1994 | 353 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 1993 | 364 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1985 | 4544 | 0.010 |
Why?
|
| Hydrogen Sulfide | 1 | 1994 | 141 | 0.010 |
Why?
|
| Breath Tests | 1 | 1994 | 299 | 0.010 |
Why?
|
| Ligation | 1 | 1993 | 448 | 0.010 |
Why?
|
| Massachusetts | 1 | 1985 | 8833 | 0.010 |
Why?
|
| Cholangitis | 1 | 1993 | 111 | 0.010 |
Why?
|
| Taste | 1 | 1993 | 189 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1987 | 18966 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1994 | 672 | 0.010 |
Why?
|
| Smell | 1 | 1993 | 259 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1986 | 8002 | 0.010 |
Why?
|
| Obesity | 2 | 1991 | 12947 | 0.010 |
Why?
|
| Infant | 1 | 1991 | 36193 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1991 | 42232 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1988 | 26202 | 0.000 |
Why?
|
| Mutation | 1 | 1991 | 30053 | 0.000 |
Why?
|
| Energy Intake | 1 | 1993 | 2134 | 0.000 |
Why?
|
| Analysis of Variance | 1 | 1993 | 6228 | 0.000 |
Why?
|
| Cimetidine | 1 | 1983 | 76 | 0.000 |
Why?
|
| Gastric Acid | 1 | 1983 | 99 | 0.000 |
Why?
|
| Esophagitis, Peptic | 1 | 1983 | 76 | 0.000 |
Why?
|
| Weight Gain | 1 | 1993 | 2348 | 0.000 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1993 | 8181 | 0.000 |
Why?
|
| Feeding Behavior | 1 | 1994 | 3188 | 0.000 |
Why?
|
| Alcoholism | 1 | 1991 | 1973 | 0.000 |
Why?
|
| Drug Resistance | 1 | 1983 | 1596 | 0.000 |
Why?
|
| Kinetics | 1 | 1983 | 6374 | 0.000 |
Why?
|